Susquehanna International Group, LLP Atai Life Sciences N.V. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$1.27 - $2.6 $86,106 - $176,280	-67,800 Reduced 84.01%	12,900 $17,000
Q1 2024 May 07, 2024	BUY	$1.5 - $2.19 $121,050 - $176,733	80,700 New	80,700 $158,000
Q3 2023 Nov 14, 2023	SELL	$1.27 - $2.28 $38,354 - $68,856	-30,200 Reduced 72.95%	11,200 $14,000
Q2 2023 Aug 11, 2023	BUY	$1.44 - $2.19 $27,648 - $42,048	19,200 Added 86.49%	41,400 $71,000
Q1 2023 May 16, 2023	SELL	$1.17 - $2.7 $304,200 - $702,000	-260,000 Reduced 92.13%	22,200 $40,000
Q4 2022 Feb 14, 2023	BUY	$2.38 - $3.55 $358,428 - $534,630	150,600 Added 114.44%	282,200 $750,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $4.87 $138,474 - $214,767	44,100 Added 50.4%	131,600 $436,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $245M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.